Is Ozempic Really Causing Hair Loss?
Hair loss is among the most commonly searched side effects of GLP-1 medications, and it's a legitimate concern. But the clinical picture is more nuanced than "Ozempic causes hair loss."
A pharmacovigilance analysis published in the *Journal of the European Academy of Dermatology and Venereology* examined ten years of FDA Adverse Event Reporting System (FAERS) data and found that semaglutide and tirzepatide were among the only GLP-1 receptor agonists to generate statistically significant signals for alopecia — with a Reporting Odds Ratio of 1.43 in 2022, rising to 1.55 by 2024.
A 2025 systematic review in *Cureus* confirmed the signal. However, FAERS data cannot determine true incidence rates or establish direct causation. Most importantly: no clinical research has shown that semaglutide directly damages hair follicles.
What researchers believe is actually happening is a well-understood phenomenon called telogen effluvium.
Understanding Telogen Effluvium
Telogen effluvium (TE) is a temporary, stress-triggered form of hair shedding. Under normal circumstances, about 85-90% of your hair follicles are in the anagen (active growth) phase at any time. A significant physiological stressor — surgery, illness, severe caloric restriction, or rapid weight loss — can push large numbers of follicles into the telogen (resting) phase simultaneously.
The result: noticeable shedding, typically beginning 2-4 months after the stressor. This timing is why GLP-1 users often experience hair loss just as their medication appears to be working well.
Crucially, TE is self-limiting. Hair typically begins to recover once the stressor resolves — in this case, once weight stabilizes or nutritional deficits are corrected.
A 2025 paper published in the *Journal of Cosmetic Dermatology* examined dechallenge and rechallenge cases (patients who stopped and restarted semaglutide). Positive dechallenge was observed in 25% of reported cases; positive rechallenge in 18%. This suggests some cases have a direct drug component, while the majority appear to be mediated by weight loss and nutritional restriction.
The Nutritional Connection
Eating significantly less food depletes several nutrients directly involved in hair follicle health. For GLP-1 users, the most relevant deficits are:
What Does the Research Say About Collagen?
This is where the science is moving quickly, and the findings are more promising than many people realize.
Mechanistic findings (2024, PMC): Research examining human dermal papilla cells found that collagen peptides promote proliferation and secretion of hair growth factors including EGF, HB-EGF, FGF-4, and FGF-6.
Clinical research on hair shaft quality (2025, *International Journal of Peptide Research and Therapeutics*): A randomized, double-blind, placebo-controlled trial found that low molecular weight collagen peptides significantly improved hair luster, shaft surface integrity, tensile strength, diameter, and hair density compared to placebo.
Telogen effluvium-specific research (2023, *Skin Research and Technology*): A three-month prospective randomized controlled study evaluated a supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with telogen effluvium. Results showed improvement versus the assessor-blinded control group.
Hair follicle organ culture study (2025, *Journal of Investigative Dermatology*): Human hair follicle research showed that oral collagen peptides may prevent hair loss by helping maintain follicle structure — the most mechanistically direct finding to date.
It should be noted that this research area is still developing. Effect sizes vary across studies, and long-term data is limited. But the biological rationale is sound, and the early RCT evidence is encouraging.
What Actually Helps: A Practical Summary
Address the nutritional foundation first:
Consider collagen supplementation:
Be patient with the timeline:
Telogen effluvium typically peaks within a few months of onset and resolves as weight stabilizes. For most GLP-1 users, the shedding is temporary. The goal of nutritional support is to shorten the duration and reduce severity — not to expect overnight change.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before starting any supplement regimen.*